A host susceptibility gene, DR1, facilitates influenza a virus replication by suppressing host innate immunity and enhancing viral RNA replication

Journal of Virology

Volumn 89, Issue 7, 2015, Pages 3671-3682

  Hsu, Shih Feng ^a   Su, Wen Chi ^b,c   Jeng, King Song ^a,d   Lai, Michael M C ^a,b,c  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ACADEMIA SINICA   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYTOKINE; DOWNREGULATOR OF TRANSCRIPTION 1; JANUS KINASE; RNA DIRECTED RNA POLYMERASE; STAT PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS RNA; DOWN-REGULATOR OF TRANSCRIPTION 1; PHOSPHOPROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DR1 GENE; GENE; GENE EXPRESSION; GENE SILENCING; HOST SUSCEPTIBILITY; INFLUENZA VIRUS A; INNATE IMMUNITY; INTERFERON STIMULATED GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; RNA REPLICATION; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; VIRUS REPLICATION; ANIMAL; BIOSYNTHESIS; CELL LINE; DOG; GENE EXPRESSION PROFILING; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; IMMUNOLOGY; INFLUENZA A VIRUS; METABOLISM; PHYSIOLOGY;

INFLUENZA A VIRUS;

ANIMALS; CELL LINE; DOGS; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INFLUENZA A VIRUS; INTERFERON-BETA; PHOSPHOPROTEINS; RNA, VIRAL; TRANSCRIPTION FACTORS; VIRUS REPLICATION;

EID: 84924767362     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03610-14     Document Type: Article

References (41)

1. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, Rimmelzwaan GF, Olsen B, Osterhaus AD. 2005. Characterization of a novel influenzaAvirus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79:2814-2822. http://dx.doi.org/10.1128/JVI.79.5.2814-2822.2005.
2. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. 1992. Evolution and ecology of influenza A viruses. Microbiol Rev 56:152-179.
3. Morens DM, Taubenberger JK, Fauci AS. 2009. The persistent legacy of the 1918 influenza virus. N Engl J Med 361:225-229. http://dx.doi.org/10.1056/NEJMp0904819.
4. Carr CM, Kim PS. 1994. Flu virus invasion: halfway there. Science 266: 234-236. http://dx.doi.org/10.1126/science.7939658.
5. Su WC, Chen YC, Tseng CH, Hsu PW, Tung KF, Jeng KS, Lai MM. 2013. Pooled RNAi screen identifies ubiquitin ligase Itch as crucial for influenza A virus release from the endosome during virus entry. Proc Natl Acad Sci USA 110:17516-17521. http://dx.doi.org/10.1073/pnas.1312374110.
6. O'Neill RE, Jaskunas R, Blobel G, Palese P, Moroianu J. 1995. Nuclear import of influenza virusRNAcan be mediated by viral nucleoprotein and transport factors required for protein import. J Biol Chem 270:22701-22704. http://dx.doi.org/10.1074/jbc.270.39.22701.
7. Lamb RA, Krug RM. 2001. Orthomyxoviridae: the viruses and their replication, p 1487-1530. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
8. García-Sastre A. 2011. Induction and evasion of type I interferon responses by influenza viruses. Virus Res 162:12-18. http://dx.doi.org/10.1016/j.virusres.2011.10.017.
9. Liu SY, Sanchez DJ, Cheng G. 2011. New developments in the induction and antiviral effectors of type I interferon. Curr Opin Immunol 23:57-64. http://dx.doi.org/10.1016/j.coi.2010.11.003.
10. Stark GR, Kerr IM, Williams BRG, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu Rev Biochem 67:227-264. http://dx.doi.org/10.1146/annurev.biochem.67.1.227.
11. Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, Garcia-Sastre A. 2000. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74:7989-7996. http://dx.doi.org/10.1128/JVI.74.17.7989-7996.2000.
12. Butler JE, Kadonaga JT. 2002. The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes Dev 16:2583-2592. http://dx.doi.org/10.1101/gad.1026202.
13. Smale ST, Kadonaga JT. 2003. The RNA polymerase II core promoter. Annu Rev Biochem 72:449-479. http://dx.doi.org/10.1146/annurev.biochem.72.121801.161520.
14. Goppelt A, Stelzer G, Lottspeich F, Meisterernst M. 1996. A mechanism for repression of class II gene transcription through specific binding of NC2 to TBP-promoter complexes via heterodimeric histone fold domains. EMBO J 15:3105-3116.
15. Inostroza JA, Mermelstein FH, Ha I, Lane WS, Reinberg D. 1992. Dr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcription. Cell 70:477-489. http://dx.doi.org/10.1016/0092-8674(92)90172-9.
16. Mermelstein F, Yeung K, Cao J, Inostroza JA, Erdjument-Bromage H, Eagelson K, Landsman D, Levitt P, Tempst P, Reinberg D. 1996. Requirement of a corepressor for Dr1-mediated repression of transcription. Genes Dev 10:1033-1048. http://dx.doi.org/10.1101/gad.10.8.1033.
17. Hao L, Sakurai A, Watanabe T, Sorensen E, Nidom CA, Newton MA, Ahlquist P, Kawaoka Y. 2008. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 454:890-893. http://dx.doi.org/10.1038/nature07151.
18. Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, Heuer D, Becker D, Khalil H, Ogilvie LA, Hess S, Mäurer AP, Müller E, Wolff T, Rudel T, Meyer TF. 2010. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463:818-822. http://dx.doi.org/10.1038/nature08760.
19. König R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y, Gao Q, Andrews SE, Bandyopadhyay S, De Jesus P, Tu BP, Pache L, Shih C, Orth A, Bonamy G, Miraglia L, Ideker T, García-Sastre A, Young JA, Palese P, Shaw ML, Chanda SK. 2010. Human host factors required for influenza virus replication. Nature 463:813-817. http://dx.doi.org/10.1038/nature08699.
20. Liao TL, Wu CY, Su WC, Jeng KS, Lai MM. 2010. Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication. EMBO J 29:3879-3890. http://dx.doi.org/10.1038/emboj.2010.250.
21. Yeung KC, Inostroza JA, Mermelstein FH, Kannabiran C, Reinberg D. 1994. Structure-function analysis of the TBP-binding protein Dr1 reveals a mechanism for repression of class II gene transcription. Genes Dev 8:2097-2109. http://dx.doi.org/10.1101/gad.8.17.2097.
22. Ehrhardt C, Seyer R, Hrincius ER, Eierhoff T, Wolff T, Ludwig S. 2010. Interplay between influenza A virus and the innate immune signaling. Microbes Infect 12:81-87. http://dx.doi.org/10.1016/j.micinf.2009.09.007.
23. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485. http://dx.doi.org/10.1038/nature09907.
24. Eierhoff T, Ludwig S, Ehrhardt C. 2009. The influenza A virus matrix protein as a marker to monitor initial virus internalisation. Biol Chem 390:509-515. http://dx.doi.org/10.1515/BC.2009.053.
25. Law AH, Lee DC, Yuen KY, Peiris M, Lau AS. 2010. Cellular response to influenza virus infection: a potential role for autophagy in CXCL10 and interferon-alpha induction. Cell Mol Immunol 7:263-270. http://dx.doi.org/10.1038/cmi.2010.25.
26. Li Z, Watanabe T, Hatta M, Watanabe S, Nanbo A, Ozawa M, Kakugawa S, Shimojima M, Yamada S, Neumann G, Kawaoka Y. 2009. Mutational analysis of conserved amino acids in the influenza A virus nucleoprotein. J Virol 83:4153-4162. http://dx.doi.org/10.1128/JVI.02642-08.
27. Müller KH, Kakkola L, Nagaraj AS, Cheltsov AV, Anastasina M, Kainov DE. 2012. Emerging cellular targets for influenza antiviral agents. Trends Pharmacol Sci 33:89-99. http://dx.doi.org/10.1016/j.tips.2011.10.004.
28. Zhao C, Hsiang TY, Kuo RL, Krug RM. 2010. ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad Sci USA 107:2253-2258. http://dx.doi.org/10.1073/pnas.0909144107.
29. Haller O, Stertz S, Kochs G. 2007. The Mx GTPase family of interferoninduced antiviral proteins. Microbes Infect 9:1636-1643. http://dx.doi.org/10.1016/j.micinf.2007.09.010.
30. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, Elledge SJ. 2009. The IFITM proteins mediate cellular resistance to influenzaAH1N1 virus, West Nile virus, and dengue virus. Cell 139:1243-1254. http://dx.doi.org/10.1016/j.cell.2009.12.017.
31. Pérez-González A, Rodriguez A, Huarte M, Salanueva IJ, Nieto A. 2006. hCLE/CGI-99, a human protein that interacts with the influenza virus polymerase, is a mRNA transcription modulator. J Mol Biol 362:887-900. http://dx.doi.org/10.1016/j.jmb.2006.07.085.
32. Zhang J, Li G, Ye X. 2010. Cyclin T1/CDK9 interacts with influenza A virus polymerase and facilitates its association with cellularRNApolymerase II. J Virol 84:12619-12627. http://dx.doi.org/10.1128/JVI.01696-10.
33. Kawaguchi A, Nagata K. 2007. De novo replication of the influenza virus RNA genome is regulated by DNA replicative helicase, MCM. EMBO J 26:4566-4575. http://dx.doi.org/10.1038/sj.emboj.7601881.
34. Naito T, Kiyasu Y, Sugiyama K, Kimura A, Nakano R, Matsukage A, Nagata K. 2007. An influenza virus replicon system in yeast identified Tat-SF1 as a stimulatory host factor for viral RNA synthesis. Proc Natl Acad Sci USA 104:18235-18240. http://dx.doi.org/10.1073/pnas.0705856104.
35. Kraus VB, Inostroza JA, Yeung K, Reinberg D, Nevins JR. 1994. Interaction of the Dr1 inhibitory factor with the TATA binding protein is disrupted by adenovirus E1A. Proc Natl Acad Sci USA 91:6279-6282. http://dx.doi.org/10.1073/pnas.91.14.6279.
36. Willy PJ, Kobayashi R, Kadonaga JT. 2000. A basal transcription factor that activates or represses transcription. Science 290:982-985. http://dx.doi.org/10.1126/science.290.5493.982.
37. Burke TW, Kadonaga JT. 1997. The downstream core promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila. Genes Dev 11:3020-3031. http://dx.doi.org/10.1101/gad.11.22.3020.
38. Castaño E, Gross P, Wang Z, Roeder RG, Oelgeschläger T. 2000. The C-terminal domain-phosphorylated IIO form of RNA polymerase II is associated with the transcription repressor NC2 (Dr1/DRAP1) and is required for transcription activation in human nuclear extracts. Proc Natl Acad SciUSA97:7184-7189. http://dx.doi.org/10.1073/pnas.140202297.
39. Burch J, Corbett M, Stock C, Nicholson K, Elliot AJ, Duffy S, Westwood M, Palmer S, Stewart L. 2009. Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis 9:537-545. http://dx.doi.org/10.1016/S1473-3099(09)70199-9.
40. Ward P, Small I, Smith J, Suter P, Dutkowski R. 2005. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother 55(Suppl 1):i5-i21. http://dx.doi.org/10.1093/jac/dki018.
41. Geisberg JV, Holstege FC, Young RA, Struhl K. 2001. Yeast NC2 associates with the RNA polymerase II preinitiation complex and selectively affects transcription in vivo. Mol Cell Biol 21:2736-2742. http://dx.doi.org/10.1128/MCB.21.8.2736-2742.2001.